[1]
Goodacre, R.; Vaidyanathan, S.; Dunn, W.B.; Harrigan, G.G.; Kell, D.B. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol., 2004, 22, 245-252.
[2]
Morel, N.M.; Holland, J.M.; van der Greef, J.; Marple, E.W.; Clish, C.; Loscalzo, J.; Naylor, S. Primer on medical genomics. Part XIV: Introduction to systems biology--a new approach to understanding disease and treatment. Mayo Clin. Proc., 2004, 79(5), 651-658.
[3]
Peng, B.; Li, H.; Peng, X.X. Functional metabolomics: from biomarker discovery to metabolome reprogramming. Protein Cell, 2015, 6(9), 628-637.
[4]
Zhang, A.; Sun, H.; Wang, P.; Han, Y.; Wang, X. Modern analytical techniques in metabolomics analysis. Modern analytical techniques in metabolomics analysis. Analyst, 2012, 137(2), 293-300.
[5]
Gowda, G.A.N.; Zhang, S.; Gu, H.; Asiago, V.; Shanaiah, N.; Raftery, D. Metabolomics-based Methods for Early Disease Diagnostics: A Review. Expert Rev. Mol. Diagn., 2008, 8(5), 617-633.
[6]
Gebregiworgis, T.; Powers, R. Application of NMR metabolomics to search for human disease biomarkers. Comb. Chem. High Throughput Screen., 2012, 15(8), 595-610.
[7]
Oliver, S.G. Functional genomics: lessons from yeast. Philos. Trans. R. Soc. Lond. B, 2002, 357, 17-23.
[8]
Ramirez, T.; Daneshian, M.; Kamp, H.; Bois, F.Y.; Clench, M.R.; Coen, M.; Donley, B.; Fischer, S.M.; Ekman, D.R.; Fabian, E.; Guillou, C.; Heuer, J.; Hogberg, H.T.; Jungnickel, H.; Keun, H.C.; Krennrich, G.; Krupp, E.; Luch, A.; Noor, F.; Peter, E.; Riefke, B.; Seymour, M.; Skinner, N.; Smirnova, L.; Verheij, E.; Wagner, S.; Hartung, T.; van Ravenzwaay, B.; Leist, M. Metabolomics in toxicology and preclinical research. ALTEX, 2013, 30(2), 209-225.
[9]
Roberts, L.D.; Souza, A.L.; Gerszten, R.E.; Clish, C.B. Targeted Metabolomics. In: Curr. Protoc. Mol. Biol; , 2012; Chapter 30, p. Unit30.2, 1-24.
[10]
Cajka, T.; Fiehn, O. Toward merging untargeted and targeted methods in mass spectrometry-based metabolomics and lipidomics. Anal. Chem., 2016, 88(1), 524-545.
[11]
Monteiro, M.S.; Carvalho, M.; Bastos, M.L.; Guedes de Pinho, P. Metabolomics analysis for biomarker discovery: advances and challenges. Curr. Med. Chem., 2013, 20(2), 257-271.
[12]
Nicholson, J.K.; Lindon, J.C. Systems biology: Metabonomics. Nature, 2008, 455(7216), 1054-1056.
[13]
Kitteringham, N.R.; Jenkins, R.E.; Lane, C.S.; Elliott, V.L.; Park, B.K. Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877(13), 1229-1239.
[14]
Zhang, A.; Hui, Sun H.; Yan, G.; Wang, P.; Wang, X. Metabolomics for biomarker discovery: Moving to the clinic. BioMed Res. Int., 2015, 354671, 1-6.
[15]
Mayeux, R. Biomarkers: Potential Uses and Limitations. NeuroRx, 2004, 2, 182-188.
[16]
Shackleton, C.H.L. Profiling steroid hormones and urinary steroids. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 1986, 379, 91-156.
[17]
Shackleton, C.H.L. Mass spectrometry: application to steroid and peptide research. Endocr. Rev., 1985, 6, 441-486.
[18]
Sanderson, J.T. The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals. Toxicol. Sci., 2006, 94(1), 3-21.
[19]
Hammond, G.L. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J. Endocrinol., 2016, 230(1), R13-R25.
[20]
Lord, R.S.; J., Bralley A. Laboratory Evaluations for Integrative and Functional Medicine, 2nd ed; Metametrix Institute, 2008.
[21]
Kotłowska, A. Application of steroid hormone metabolomics in search of biomarkers in clinical research. Drug Dev. Res., 2012, 73(7), 381-389.
[22]
Oresic, M. Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction. Nutr. Metab. Cardiovasc. Dis., 2009, 19(11), 816-824.
[23]
Mulvihill, M.M.; Nomura, D.K. Metabolomic strategies to map functions of metabolic pathways. Am. J. Physiol. Endocrinol. Metab., 2014, 307(3), E237-E244.
[24]
Mandrekar, S.J.; Sargent, D.J. Clinical trial designs for predictive biomarker validation: one size does not fit all. J. Biopharm. Stat., 2009, 19(3), 530-542.
[25]
Rege, J.; Rainey, W.E. The steroid metabolome of adrenarche. J. Endocrinol., 2012, 214(2), 133-143.
[26]
Kushnir, M.M.; Rockwood, A.L.; Roberts, W.L.; Yue, B.; Bergquist, J.; Meikle, A.W. Liquid chromatography tandem mass spectrometry for analysis of steroids in clinical laboratories. Clin. Biochem., 2011, 44(1), 77-88.
[27]
Kotłowska, A.; Sworczak, K.; Stepnowski, P. Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2011, 879(5-6), 359-363.
[28]
Caruso, D.; Melis, M.; Fenu, G.; Giatti, S.; Romano, S.; Grimoldi, M.; Crippa, D.; Marrosu, M.G.; Cavaletti, G.; Melcangi, R.C. Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients. J. Neurochem., 2014, 130(4), 591-597.
[29]
Flores-Valverde, A.M.; Hill, E.M. Methodology for profiling the steroid metabolome in animal tissues using ultraperformance liquid chromatography-electrospray-time-of-flight mass spectrometry. Anal. Chem., 2008, 80(22), 8771-8779.
[30]
McDonald, J.G.; Matthew, S.; Auchus, R.J. Steroid profiling by gas chromatography-mass spectrometry and high performance liquid chromatography-mass spectrometry for adrenal diseases. Horm. Cancer, 2011, 2(6), 324-332.
[31]
Ceglarek, U.; Werner, M.; Kortz, L.; Körner, A.; Kiess, W.; Thiery, J.; Kratzsch, J. Preclinical challenges in steroid analysis of human samples. J. Steroid Biochem. Mol. Biol., 2010, 121(3-5), 505-512.
[32]
Toone, R.J.; Peacock, O.J.; Smith, A.A.; Thompson, D.; Drawer, S.; Cook, C.; Stokes, K.A. Measurement of steroid hormones in saliva: Effects of sample storage condition. Scand. J. Clin. Lab. Invest., 2013, 73(8), 615-621.
[33]
Taylor, P.J. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin. Biochem., 2005, 38(4), 328-334.
[34]
Fischer, R.; Bowness, P.; Kessler, B.M. Two birds with one stone: Doing metabolomics with your proteomics kit. Proteomics, 2013, 13(23-24), 3371-3386.
[35]
Bruce, S.J.; Tavazzi, I.; Parisod, V.; Rezzi, S.; Kochhar, S.; Guy, P.A. Investigation of human blood plasma sample preparation for performing metabolomics using ultrahigh performance liquid chromatography/mass spectrometry. Anal. Chem., 2009, 81(9), 3285-3296.
[36]
Broccardo, C.J.; Schauer, K.L.; Kohrt, W.M.; Schwartz, R.S.; Murphy, J.P.; Prenni, J.E. Multiplexed analysis of steroid hormones in human serum using novel microflow tile technology and LC-MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 934, 16-21.
[37]
Bylda, C.; Thiele, R.; Kobolda, U.; Volmer, D.A. Recent advances in sample preparation techniques to overcome difficulties encountered during quantitative analysis of small molecules from biofluids using LC-MS/MS. Analyst, 2014, 139, 2265-2276.
[38]
Koren, L.; Ng, E.S.; Soma, K.K.; Wynne-Edwards, K.E. Sample preparation and liquid chromatography-tandem mass spectrometry for multiple steroids in mammalian and avian circulation. PLoS One, 2012, 7(2), e32496.
[39]
Noppe, H.; Verheyden, K.; Gillis, W.; Courtheyn, D.; Vanthemsche, P.; De Brabander, H.F. Multi-analyte approach for the determination of ng L(-1) levels of steroid hormones in unidentified aqueous samples. Anal. Chim. Acta, 2007, 586(1-2), 22-29.
[40]
Allende, F.; Solari, S.; Campino, C.; Carvajal, C.A.; Lagos, C.F.; Vecchiola, A.; Valdivia, C.; Baudrand, R.; Owen, G.I.; Fardella, C.E. LC-MS/MS method for the simultaneous determination of free urinary steroids. Chromatographia, 2014, 77, 637-642.
[41]
Moon, J.Y.; Kim, K.J.; Moon, M.H.; Chung, B.C.; Choi, M.H. A novel GC-MS method in urinary estrogen analysis from postmenopausal women with osteoporosis. J. Lipid Res., 2011, 52(8), 1595-1603.
[42]
Kaklamanos, G.; Theodoridis, G.; Dabalis, T. Determination of anabolic steroids in muscle tissue by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A, 2009, 1216(46), 8072-8079.
[43]
Chen, J.; Liang, Q.; Hua, H.; Wang, Y.; Luo, G.; Hu, M.; Na, Y. Simultaneous determination of 15 steroids in rat blood via gas chromatography-mass spectrometry to evaluate the impact of emasculation on adrenal. Talanta, 2009, 80(2), 826-832.
[44]
Jung, H.J.; Kim, S.J.; Lee, W.Y.; Chung, B.C.; Choi, M.H. Gas chromatography/mass spectrometry based hair steroid profiling may reveal pathogenesis in hair follicles of the scalp. Rapid Commun. Mass Spectrom., 2011, 25(9), 1184-1192.
[45]
Choi, M.H.; Moon, J.Y.; Cho, S.H.; Chung, B.C.; Lee, E.J. Metabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinoma. BMC Cancer, 2011, 11, 342.
[46]
Aufartová, J.; Mahugo-Santana, C.; Sosa-Ferrera, Z.; Santana-Rodríguez, J.J.; Nováková, L.; Solich, P. Determination of steroid hormones in biological and environmental samples using green microextraction techniques: an overview. Anal. Chim. Acta, 2011, 704(1-2), 33-46.
[47]
Peñalver, A.; Pocurull, E.; Borrull, F.; Marcé, R.M. Method based on solid-phase microextraction--high-performance liquid chromatography with UV and electrochemical detection to determine estrogenic compounds in water samples. J. Chromatogr. A, 2002, 964(1-2), 153-160.
[48]
Zhang, Z.; Duan, H.; Zhang, L.; Chen, X.; Liu, W.; Chen, G. Direct determination of anabolic steroids in pig urine by a new SPME-GC-MS method. Talanta, 2009, 78(3), 1083-1089.
[49]
Yang, L.; Luan, T.; Lan, C. Solid-phase microextraction with on-fiber silylation for simultaneous determinations of endocrine disrupting chemicals and steroid hormones by gas chromatography-mass spectrometry. J. Chromatogr. A, 2006, 1104(1-2), 23-32.
[50]
Vo Duy, S.; Fayad, P.B.; Barbeau, B.; Prévost, M.; Sauvé, S. Using a novel sol-gel stir bar sorptive extraction method for the analysis of steroid hormones in water by laser diode thermal desorption/atmospheric chemical ionization tandem mass spectrometry. Talanta, 2012, 101, 337-345.
[51]
Huang, X.; Qiu, N.; Yuan, D.; Huang, B. A novel stir bar sorptive extraction coating based on monolithic material for apolar, polar organic compounds and heavy metal ions. Talanta, 2009, 78(1), 101-106.
[52]
Huang, X.; Yuan, D.; Huang, B. Determination of steroid sex hormones in urine matrix by stir bar sorptive extraction based on monolithic material and liquid chromatography with diode array detection. Talanta, 2008, 75(1), 172-177.
[53]
Tienpont, B.; David, F.; Desmet, K.; Sandra, P. Stir bar sorptive extraction-thermal desorption-capillary GC-MS applied to biological fluids. Anal. Bioanal. Chem., 2002, 373(1-2), 46-55.
[54]
Doué, M.; Bichon, E.; Dervilly-Pinel, G.; Pichon, V.; Chapuis-Hugon, F.; Lesellier, E.; West, C.; Monteau, F.; Le Bizec, B. Molecularly imprinted polymer applied to the selective isolation of urinary steroid hormones: an efficient tool in the control of natural steroid hormones abuse in cattle. J. Chromatogr. A, 2012, 1270, 51-61.
[55]
Gañán, J.; Morante-Zarcero, S.; Gallego-Picó, A.; Garcinuño, R.M.; Fernández-Hernando, P.; Sierra, I. Evaluation of a molecularly imprinted polymer for determination of steroids in goat milk by matrix solid phase dispersion. Talanta, 2014, 126, 157-162.
[56]
Gadzała-Kopciuch, R.; Ricanyová, J.; Buszewski, B. Isolation and detection of steroids from human urine by molecularly imprinted solid-phase extraction and liquid chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2009, 877(11-12), 1177-1184.
[57]
Ferchaud, V.; Courcoux, P.; Le Bizec, B.; Monteau, F.; André, F. Enzymatic hydrolysis of conjugated steroid metabolites: search for optimum conditions using response surface methodology. Analyst, 2000, 125(12), 2255-2259.
[58]
Shibasaki, H.; Tanabe, C.; Furuta, T.; Kasuya, Y. Hydrolysis of conjugated steroids by the combined use of beta-glucuronidase preparations from helix pomatia and ampullaria: determination of urinary cortisol and its metabolites. Steroids, 2001, 66(11), 795-801.
[59]
Bradlow, H.L. In: Chemical and Biological Aspects of Steroid Conjugation; Bernstein, S.; Solomon, S., Eds.; Springer Berlin Heidelberg, 1970, pp. 131-181.
[60]
Sadanala, K.C.; Lee, J.; Chung, B.C.; Choi, M.H. Targeted metabolite profiling: Sample preparation techniques for GC-MS-based steroid analysis. Mass Spectrometry Letters, 2012, 3(1), 4-9.
[61]
Zaikin, V.; Halket, J.M. A Handbook of Derivatives for Mass Spectrometry; IM Publications LPP, 2009.
[62]
Gao, S.; Zhang, Z.P.; Karnes, H.T. Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2005, 825(2), 98-110.
[63]
Kirk, J.M.; Tarbin, J.; Keely, B.J. Analysis of androgenic steroid Girard P hydrazones using multistage tandem mass spectrometry. Rapid Commun. Mass Spectrom., 2006, 20(8), 1247-1252.
[64]
Athanasiadou, I.; Angelis, Y.S.; Lyris, E.; Georgakopoulos, C. Chemical derivatization to enhance ionization of anabolic steroids in LC-MS for doping-control analysis. TrAC, 2013, 42, 137-156.
[65]
Gao, W.; Kirschbaum, C.; Grass, J. Stalder T. LC-MS based analysis of endogenous steroid hormones in human hair. J. Steroid Biochem. Mol. Biol., 2016, 162, 92-99.
[66]
Stanczyk, F.Z.; Clarke, N.J. Advantages and challenges of mass spectrometry assays for steroid hormones. J. Steroid Biochem. Mol. Biol., 2010, 121(3-5), 491-495.
[67]
Plenis, A.; Miękus, N.; Olędzka, I.; Bączek, T.; Lewczuk, A.; Woźniak, Z.; Koszałka, P.; Seroczyńska, B.; Skokowski, J. Chemometric evaluation of urinary steroid hormone levels as potential biomarkers of neuroendocrine tumors. Molecules, 2013, 18(10), 12857-1276.
[68]
Almeida, C.; Nogueira, J.M. Determination of steroid sex hormones in water and urine matrices by stir bar sorptive extraction and liquid chromatography with diode array detection. J. Pharm. Biomed. Anal., 2006, 41(4), 1303-1311.
[69]
Shimada, K.; Mitamura, K.; Higashi, T. Gas chromatography and high-performance liquid chromatography of natural steroids. J. Chromatogr. A, 2001, 935(1-2), 141-172.
[70]
Juricskay, S.; Telegdy, E. Urinary steroids in women with androgenic alopecia. Clin. Biochem., 2000, 33(2), 97-101.
[71]
Krone, N.; Hughes, B.A.; Lavery, G.G.; Stewart, P.M.; Arlt, W.; Shackleton, C.H.L. Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J. Steroid Biochem. Mol. Biol., 2010, 121(3-5), 496-504.
[72]
Penning, T.M.; Lee, S.H.; Jin, Y.; Gutierrez, A.; Blair, I.A. Liquid chromatography-mass spectrometry (LC-MS) of steroid hormone metabolites and its applications. J. Steroid Biochem. Mol. Biol., 2010, 121(3-5), 546-555.
[73]
Leinonen, A.; Kuuranne, T.; Kostiainen, R. Liquid chromatography/mass spectrometry in anabolic steroid analysis--optimization and comparison of three ionization techniques: electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization. J. Mass Spectrom., 2002, 37(7), 693-698.
[74]
Annesley, T.M. Ion suppression in mass spectrometry. Clin. Chem., 2003, 49(7), 1041-1044.
[75]
Soldin, S.J.; Soldin, O.P. Steroid hormone analysis by tandem mass spectrometry. Clin. Chem., 2009, 55(6), 1061-1066.
[76]
Gertsman, I.; Gangoiti, J.A.; Barshop, B.A. Validation of a dual LC-HRMS platform for clinical metabolic diagnosis in serum, bridging quantitative analysis and untargeted metabolomics. Metabolomics, 2014, 10(2), 312-323.
[77]
Haneef, J.; Shaharyar, M.; Husain, A.; Rashid, M.; Mishra, R.; Parveen, S.; Ahmed, N.; Pal, M.; Kumar, D. Application of LC-MS/MS for quantitative analysis of glucocorticoids and stimulants in biological fluids. Journal of Pharmaceutical Analysis, 2013, 3(5), 341-348.
[78]
Lamparczyk, H. CRC Handbook of Chromatography: Analysis and Characterization of Steroids; CRC Press, 1992.
[79]
Kotłowska, A.; Maliński, E.; Sworczak, K.; Kumirska, J.; Stepnowski, P. The urinary steroid profile in patients diagnosed with adrenal incidentaloma. Clin. Biochem., 2009, 42(6), 448-454.
[80]
Caulfield, M.P.; Lynn, T.; Gottschalk, M.E.; Jones, K.L.; Taylor, N.F.; Malunowicz, E.M.; Shackleton, C.H.L.; Reitz, R.E.; Fisher, D.A. The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. J. Clin. Endocrinol. Metab., 2002, 87(8), 3682-3690.
[81]
Moon, J.; Ha, Y.; Moon, M.; Chung, B.; Choi, M. Systematic error in gas chromatography-mass spectrometry based quantitation of hydrolyzed urinary steroids. Cancer Epidemiol. Biomarkers Prev., 2010, 19, 388-397.
[82]
Moon, J.; Jung, H.; Moon, M.; Chung, B.; Choi, M. Heat-map visualization of gas chromatography-mass spectrometry based quantitative signatures on second steroids metabolism. J. Am. Soc. Mass Spectrom., 2009, 20, 1626-1637.
[83]
Hauser, B.; Deschner, T.; Boesch, C. Development of a liquid chromatography-tandem mass spectrometry method for the determination of 23 endogenous steroids in small quantities of primate urine. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2008, 862(1-2), 100-112.
[84]
Naldi, A.C.; Fayad, P.B.; Prévost, M.; Sauvé, S. Analysis of steroid hormones and their conjugated forms in water and urine by on-line solid-phase extraction coupled to liquid chromatography tandem mass spectrometry. Chem. Cent. J., 2016, 10, 30.
[85]
Yan, Z.; Cheng, C.; Liu, S. In: LC-MS in Drug Bioanalysis; Xu, Q.A.; Madden, T.L., Eds.; Springer, US, 2012, pp. 251-286.
[86]
Santen, R.J.; Demers, L.; Ohorodnik, S.; Settlage, J.; Langecker, P.; Blanchett, D.; Gosse, P.E.; Wang, S. Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS)for estradiol for monitoring of aromatase inhibitor therapy. Steroids, 2007, 72, 666-671.
[87]
Cook, D.W.; Rutan, S.C. Chemometrics for the analysis of chromatographic data in metabolomics investigations. J. Chemometr., 2014, 9, 681-687.
[88]
Kotłowska, A. Application of chemometric techniques in search of clinically applicable biomarkers of disease. Drug Dev. Res., 2014, 75(5), 283-290.
[89]
Dessì, N.; Pascariello, E.; Pes, B. A comparative analysis of biomarker selection techniques. BioMed Res. Int., 2013, 2013, 387673.
[90]
Zarogianni, E.; Moorhead, T.W.; Lawrie, S.M. Towards the identification of imaging biomarkers in schizophrenia, using multivariate pattern classification at a single-subject level. Neuroimage Clin., 2013, 3, 279-289.
[91]
Nagana Gowda, G.A.; Raftery, D. Biomarker Discovery and Translation in Metabolomics. Curr. Metabolomics, 2013, 1(3), 227-240.
[92]
Nagana Gowda, G.A.; Zhang, S.; Gu, H.; Asiago, V.; Shanaiah, N.; Raftery, D. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn., 2008, 8(5), 617-633.
[93]
Tomasi, G.; van den Berg, F.; Andersson, C. Correlation optimized warping and dynamic time warping as preprocessing methods for chromatographic data. J. Chemometr., 2004, 18(5), 231-241.
[94]
Struck, W.; Wiczling, P.; Waszczuk-Jankowska, M.; Kaliszan, R.; Markuszewski, M.J. New supervised alignment method as a preprocessing tool for chromatographic data in metabolomic studies. J. Chromatogr. A, 2012, 1256, 150-159.
[95]
Ahn, J.K.; Kim, S.; Hwang, J.; Kim, J.; Lee, Y.S.; Koh, E.M.; Kim, K.H.; Cha, H.S. Metabolomic Elucidation of the Effects of Curcumin on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis. PLoS One, 2015, 10(12), e0145539.
[96]
Cuperlović-Culf, M.; Belacel, N.; Culf, A.S.; Chute, I.C.; Ouellette, R.J.; Burton, I.W.; Karakach, T.K.; Walter, J.A. NMR metabolic analysis of samples using fuzzy K-means clustering. Magn. Reson. Chem., 2009, 47(l), S96-S104.
[97]
Yamamoto, H.; Yamaji, H.; Abe, Y.; Harada, K.; Waluyo, D.; Fukusaki, E.; Kondo, A.; Ohno, H.; Fukuda, H. Dimensionality reduction for metabolome data using PCA, PLS, OPLS, and RFDA with differential penalties to latent variables. Chemom. Intell. Lab. Syst., 2009, 98(2), 136-142.
[98]
Alonso, A.; Marsal, S.; Julià, A. Analytical Methods in Untargeted Metabolomics: State of the Art in 2015. Front. Bioeng. Biotechnol., 2015, 3, 3-20.
[99]
Worley, B.; Powers, R. Multivariate Analysis in Metabolomic. Curr. Metabolomics, 2013, 1(1), 92-107.
[100]
Jiang, J.H.; Wang, J.H.; Chu, X.; Yu, R.Q. Neural network learning to non-linear principal component analysis. Anal. Chim. Acta, 1996, 336, 209-222.
[101]
Rantalainen, M.; Bylesjö, M.; Cloarec, O.; Nicholson, J.K.; Holmes, E.; Trygg, J. Kernel-based orthogonal projections to latent structures (K-OPLS). J. Chemometr., 2007, 21, 376-38.
[102]
Rubingh, C.M.; Bijlsma, S.; Derks, E.P.; Bobeldijk, I.; Verheij, E.R.; Kochhar, S.; Smilde, A.K. Assessing the performance of statistical validation tools for megavariate metabolomics data. Metabolomics, 2006, 2(2), 53-61.
[103]
Bro, R.; Kjeldahl, K.; Smilde, A.K.; Kiers, H.A. Cross-validation of component models: a critical look at current methods. Anal. Bioanal. Chem., 2008, 390(5), 1241-1251.
[104]
Hajian-Tilaki, K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J. Intern. Med., 2013, 4(2), 627-635.
[105]
Vexler, A.; Chen, X.; Yu, J. Evaluations and comparisons of treatment effects based on best combinations of biomarkers with applications to biomedical studies. J. Comput. Biol., 2014, 21(9), 709-721.
[106]
Ma, Y.C.; Kim, H.Y. Determination of Steroids by Liquid Chromatography/Mass Spectrometry. J. Am. Soc. Mass Spectrom., 1997, 8(9), 1010-1020.
[107]
Rauh, M. Steroid measurement with LC-MS/MS. Application examples in pediatrics. J. Steroid Biochem. Mol. Biol., 2010, 121(3-5), 520-527.
[108]
Kalogera, E.; Pistos, C.; Provatopoulou, X.; Christophi, C.A.; Zografos, G.C.; Stefanidou, M.; Spiliopoulou, C.; Athanaselis, S.; Gounaris, A. Bioanalytical LC-MS Method for the Quantification of Plasma Androgens and Androgen Glucuronides in Breast Cancer. J. Chromatogr. Sci., 2016, 54(4), 583-592.
[109]
Konieczna, L.; Bączek, T.; Belka, M.; Fel, A.; Markuszewski, M.; Struck, W.; Markuszewski, M.; Kaliszan, R. Steroid profiles as potential biomarkers in patients with urogenital tract cancer for diagnostic investigations analyzed by liquid chromatography coupled to mass spectrometry. J. Pharm. Biomed. Anal., 2013, 73, 108-115.
[110]
Bicikova, M.; Hill, M.; Ripova, D.; Mohr, P.; Hampl, R. Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J. Steroid Biochem. Mol. Biol., 2013, 133, 77-83.
[111]
Vaňková, M.; Hill, M.; Velíková, M.; Včelák, J.; Vacínová, G.; Dvořáková, K.; Lukášová, P.; Vejražková, D.; Rusina, R.; Holmerová, I.; Jarolímová, E.; Vaňková, H.; Kancheva, R.; Bendlová, B.; Stárka, L. Preliminary evidence of altered steroidogenesis in women with Alzheimer’s disease: Have the patients “OLDER” adrenal zona reticularis? J. Steroid Biochem. Mol. Biol., 2016, 158, 157-177.
[112]
Arlt, W.; Biehl, M.; Taylor, A.E.; Hahner, S.; Libé, R.; Hughes, B.A.; Schneider, P.; Smith, D.J.; Stiekema, H.; Krone, N.; Porfiri, E.; Opocher, G.; Bertherat, J.; Mantero, F.; Allolio, B.; Terzolo, M.; Nightingale, P.; Shackleton, C.H.L.; Bertagna, X.; Fassnacht, M.; Stewart, P.M. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors. J. Clin. Endocrinol. Metab., 2011, 96(12), 3775-3784.
[113]
Kao, P.C.; Machacek, D.A.; Magera, M.J.; Lacey, J.M.; Rinaldo, P. Diagnosis of adrenal cortical dysfunction by liquid chromatography-tandem mass spectrometry. Ann. Clin. Lab. Sci., 2001, 31(2), 199-204.
[114]
Cheng, J.; Ma, X.; Krausz, K.W.; Idle, J.R.; Gonzalez, F.J. Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity. Drug Metab. Dispos., 2009, 37(8), 1611-1621.
[115]
Kim, B.; Moon, J.Y.; Choi, M.H.; Yang, H.H.; Lee, S.; Lim, K.S.; Yoon, S.H.; Yu, K.S.; Jang, I.J.; Cho, J.Y. Global metabolomics and targeted steroid profiling reveal that rifampin, a strong human PXR activator, alters endogenous urinary steroid markers. J. Proteome Res., 2013, 12(3), 1359-1368.
[116]
McManus, F.; Fraser, R.; Davies, E.; Connell, J.M.; Freel, E.M. Plasma steroid profiling and response to trophins to illustrate intra-adrenal dynamics. J. Endocrinol., 2015, 224(2), 149-157.
[117]
Badoud, F.; Boccard, J.; Schweizer, C.; Pralong, F.; Saugy, M.; Baume, N. Profiling of steroid metabolites after transdermal and oral administration of testosterone by ultra-high pressure liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. J. Steroid Biochem. Mol. Biol., 2013, 138, 222-235.
[118]
Norli, H.R.; Esbensen, K.; Westad, F.; Birkeland, K.I.; Hemmersbach, P. Chemometric evaluation of urinary steroid profiles in doping control. J. Steroid Biochem. Mol. Biol., 1995, 54(1-2), 83-88.
[119]
Medina, S.; Ferreres, F.; García-Viguera, C.; Horcajada, M.N.; Orduna, J.; Savirón, M.; Zurek, G.; Martínez-Sanz, J.M.; Gil, J.I.; Gil-Izquierdo, A. Non-targeted metabolomic approach reveals urinary metabolites linked to steroid biosynthesis pathway after ingestion of citrus juice. Food Chem., 2013, 136(2), 938-946.
[120]
Keefe, C.C.; Goldman, M.M.; Zhang, K.; Clarke, N.; Reitz, R.E.; Welt, C.K. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry. PLoS One, 2014, 9(4), e93805.
Download PDF Flyer